Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Semaglutide and beyond: a turning point in obesity pharmacotherapy. | Pepdox

Home
Search
PMID 38362559

Semaglutide and beyond: a turning point in obesity pharmacotherapy.

The Lancet regional health. Europe2024PMID: 38362559

View on PubMed DOI: 10.1016/j.lanepe.2024.100860

Authors

The Lancet Regional Health-Europe,